3Dempfle CE,Alesci S,et al. Fibrin formation and proteolysis during ancrod treatment. Evidence for des - a - profibrin formation and thrombin independent factor ⅩⅢ activity. Ann N Y Acad Sci ,2001,936 :210-214.
4Izumi Y,Tsuda Y, Ichihara S, et al. Effects of defibination on hemorheology,cerebral blood flow velocity and CO2 reactivity during hypocapnia in normal subjects. Stroke,1996,27:1328 - 1332.
5Rnhsamen K, Homberger W, Kirchengast M. Inhibtion of arterial thrombus formation in two canine modles :comparison of ancord, a fibrinogen- depleting agent,the thrombin- inhibitor r- hirudin and the glycoprotein Ⅱb/Ⅲa - receptor antagonist Ro 43 - 8857. Thromb Haemost,1995,74 : 1353 - 1360.
6Sherman DG,Atkinson liP,Chippendale T,et al, Intravenous ancred for treatment of acute ischemic stroke:the STAT study :a randommized controlled trial,stroke treatment with ancred trial. JAME,2000,283:2395-2403.
7Wardlaw JM, Del Zoppo G, Yamaguchi T. Thrombolysis for acute ischemic stroke. The Cochrane Datebase Syst Rev,2003. CD000213.
8Mayberg MR, Furlan A. Acrod - is snake venom an antidote for stroke?JAMA ,2000,283:2440 -2442.
